Physician profile
William E Pauley
NPI 1770002172
$6,190.29
in general payments reported to CMS, 2019-2025
32 companies · $812 in 2025
The $812 reported for 2025 was more than what 82% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,275 · 2022: $1,467 · 2023: $1,838 · 2024: $797 · 2025: $812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,448.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,447.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,602.51 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $1,005.26 | 2021-2025 | |
| Lilly USA, LLC | $641.35 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Abbott Laboratories | $506.96 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $334.34 | 2021-2025 | Evenity, Prolia, Repatha |
| Pfizer INC. | $278.26 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $259.63 | 2021-2025 | Spravato |
| Otsuka America Pharmaceutical, INC. | $180.85 | 2022-2025 | Rexulti, Abilify Maintena |
| Astrazeneca Pharmaceuticals LP | $169.50 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $149.40 | 2021-2025 | Xifaxan |
| Boston Scientific Corporation | $122.75 | 2025 | Lux-Dx Insertable Cardiac Monitor |
| Glaxosmithkline, LLC. | $94.82 | 2021-2024 | Shingrix |
| Biohaven Pharmaceutical Holding Company LTD. | $85.74 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $85.26 | 2021-2023 | Trintellix |
| Biohaven Pharmaceuticals, INC. | $79.43 | 2021 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $78.03 | 2021-2025 | Rexulti |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.27 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $46.91 | 2023 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Idorsia Pharmaceuticals US INC | $45.78 | 2022-2023 | Quviviq |
| Alkermes, INC. | $45.41 | 2023-2024 | Vivitrol, Vivitrol |
| E.R. Squibb & Sons, L.L.C. | $45.19 | 2022-2024 | Eliquis |
| Amarin Pharma, INC. | $39.25 | 2021 | |
| Exact Sciences Corporation | $38.43 | 2023 | Cologuard Collection Kit |
| Astellas Pharma US INC | $36.13 | 2022-2025 | Veozah |
| Dexcom, INC. | $31.88 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $27.97 | 2024-2025 | Austedo Xr, Austedo Xr |
| Baxter Healthcare | $22.55 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Jazz Pharmaceuticals INC. | $20.26 | 2021 | |
| Dynavax Technologies Corporation | $17.90 | 2022 | |
| Novartis Pharmaceuticals Corporation | $16.86 | 2022 | |
| Hologic Sales and Service, LLC | $14.04 | 2024 | Thinprep 2000 Processor, Aptima |
| Almatica Pharma LLC | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Pauley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.